drugset / Trial / NCT01010945
Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is a phase 1b study to evaluate the combination of gemcitabine and Tarceva (erlotinib) and nab-paclitaxel in patients with advanced pancreatic cancer.
Timeline
- Start
- 2010-02-03
- Primary completion
- 2012-01-25
- Completion
- 2012-01-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Erlotinib | Small molecule | — | Oral |
| Subject | Gemcitabine | Small molecule | — | Intravenous |
| Subject | Nab-paclitaxel | Small molecule | — | Intravenous |